Skip Navigation

JNCI Journal of the National Cancer Institute 2006 98(8):515; doi:10.1093/jnci/djj175
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Susman, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Susman, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2006.

NEWS

NCCN Issues First Guidelines for Deep Vein Thrombosis Treatment in Cancer Patients

Ed Susman

The first 10% of the full text of this article appears below.

For oncologists pondering what agent is the right one for protecting patients against deep vein thromboses, there is little evidence that one drug is superior to another, according to the first guidelines on this condition from the National Comprehensive . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?